Risk prediction is improved by adding markers of subclinical organ damage to SCORE

被引:213
|
作者
Sehestedt, Thomas [1 ,2 ]
Jeppesen, Jorgen [1 ]
Hansen, Tine W. [2 ,3 ]
Wachtell, Kristian [4 ]
Ibsens, Hans [5 ]
Torp-Petersen, Christian [6 ]
Hildebrandt, Per [1 ]
Olsen, Michael H. [1 ]
机构
[1] Glostrup Univ Hosp, Dept Internal Med, Cardiovasc Res Unit, DK-2600 Glostrup, Denmark
[2] Res Ctr Prevent & Hlth, Copenhagen, Denmark
[3] Hvidovre Univ Hosp, Dept Clin Physiol & Nucl Med, DK-2650 Hvidovre, Denmark
[4] Rigshosp, Dept Cardiol, Copenhagen, Denmark
[5] Holbaek Cent Hosp, Dept Internal Med, Holbaek, Denmark
[6] Gentofte Univ Hosp, Dept Cardiol, Gentofte, Denmark
关键词
Risk stratification; SCORE; Atherosclerotic plaques; Albuminuria; Pulse wave velocity; Left ventricular hypertrophy; CORONARY-HEART-DISEASE; BRAIN NATRIURETIC PEPTIDE; LEFT-VENTRICULAR MASS; C-REACTIVE PROTEIN; CARDIOVASCULAR RISK; MYOCARDIAL-INFARCTION; PRIMARY HYPERTENSION; AORTIC STIFFNESS; ROC CURVE; MICROALBUMINURIA;
D O I
10.1093/eurheartj/ehp546
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims It is unclear whether subclinical vascular damage adds significantly to Systemic Coronary Risk Evaluation (SCORE) risk stratification in healthy subjects. Methods and results In a population-based sample of 1968 subjects without cardiovascular disease or diabetes not receiving any cardiovascular, anti-diabetic, or lipid-lowering treatment, aged 41, 51, 61, or 71 years, we measured traditional cardiovascular risk factors, left ventricular (LV) mass index, atherosclerotic plaques in the carotid arteries, carotid/femoral pulse wave velocity (PWV), and urine albumin/creatinine ratio (UACR) and followed them for a median of 12.8 years. Eighty-one subjects died because of cardiovascular causes. Risk of cardiovascular death was independently of SCORE associated with LV hypertrophy [hazard ratio (HR) 2.2 (95% Cl 1.2-4.0)], plaques [HR 2.5 (1.6-4.0)], UACR >= 90th percentile [HR 3.3 (1.8-5.9)], PWV > 12 m/s [HR 1.9 (1.1-3.3) for SCORE >= 5% and 7.3 (3.2-16.1) for SCORE < 5%]. Restricting primary prevention to subjects with SCORE >= 5% as well as subclinical organ damage, increased specificity of risk prediction from 75 to 81% (P < 0.002), but reduced sensitivity from 72 to 65% (P = 0.4). Broaden primary prevention from subjects with SCORE >= 5% to include subjects with 1% <= SCORE < 5% together with subclinical organ damage increased sensitivity from 72 to 89% (P = 0.006), but reduced specificity from 75 to 57% (P < 0.002) and positive predictive value from 11 to 8% (P = 0.07). Conclusion Subclinical organ damage predicted cardiovascular death independently of SCORE and the combination may improve risk prediction.
引用
收藏
页码:883 / 891
页数:9
相关论文
共 50 条
  • [31] Prevalence of Hyperuricemia and Its Association with Cardiovascular Risk Factors and Subclinical Target Organ Damage
    Antelo-Pais, Paula
    Angel Prieto-Diaz, Miguel
    Mico-Perez, Rafael M.
    Pallares-Carratala, Vicente
    Velilla-Zancada, Sonsoles
    Polo-Garcia, Jose
    Barquilla-Garcia, Alfonso
    Ginel-Mendoza, Leovigildo
    Segura-Fragoso, Antonio
    Vitelli-Storelli, Facundo
    Martin-Sanchez, Vicente
    Hermida-Ameijerias, Alvaro
    Cinza-Sanjurjo, Sergio
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (01)
  • [32] SEX DIFFERENCES AND SUBCLINICAL ORGAN DAMAGE IN CARDIOVASCULAR RISK STRATIFICATION IN PATIENTS WITH OR WITHOUT HYPERTENSION
    Posadzy-Malaczynska, Anna
    Woznicka-Leskiewicz, Lucyna
    JOURNAL OF HYPERTENSION, 2023, 41 : E137 - E137
  • [33] ASSESSMENT OF RENAL FUNCTION IN DETECTION OF SUBCLINICAL ORGAN DAMAGE AND RISK STRATIFICATION IN HYPERTENSIVE PATIENTS
    Villevalde, S.
    Tyukhmenev, E.
    Akhmetov, R.
    Kobalava, Z.
    JOURNAL OF HYPERTENSION, 2010, 28 : E588 - E588
  • [34] Assessment of Claims of Improved Prediction Beyond the Framingham Risk Score
    Tzoulaki, Ioanna
    Liberopoulos, George
    Ioannidis, John P. A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (21): : 2345 - 2352
  • [35] Adding Genetic Markers to Classic Risk Factors - An Enhanced Coronary Risk Score Based on the Morgam Prospective Cohorts
    Hughes, Maria
    Saarela, Olli
    Stritzke, Jan
    Kee, Frank
    Silander, Kaisa
    Klopp, Norman
    Kontto, Jukka
    Karvanen, Juha
    Willenborg, Christina
    Peters, Annette
    Baumert, Jens
    Thorand, Barbara
    Salomaa, Veikko
    Virtamo, Jarmo
    Amouyel, Philippe
    Arveiler, Dominique
    Ferrieres, Jean
    Wiklund, Per-Gunner
    Doering, Angela
    Diemert, Patrick
    Hengstenberg, Christian
    Samani, Nilesh
    Koenig, Wolfgang
    Erdmann, Jeanette
    Evans, Alun
    Kuulasmaa, Kari
    Schunkert, Heribert
    CIRCULATION, 2011, 124 (21)
  • [36] Subclinical Hypertension-Mediated Organ Damage (HMOD) in Hypertension: Atherosclerotic Cardiovascular Disease (ASCVD) and Calcium Score
    Rizzoni, Damiano
    Agabiti-Rosei, Claudia
    De Ciuceis, Carolina
    Boari, Gianluca Edoardo Mario
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2023, 30 (01) : 17 - 27
  • [37] Subclinical Hypertension-Mediated Organ Damage (HMOD) in Hypertension: Atherosclerotic Cardiovascular Disease (ASCVD) and Calcium Score
    Damiano Rizzoni
    Claudia Agabiti-Rosei
    Carolina De Ciuceis
    Gianluca Edoardo Mario Boari
    High Blood Pressure & Cardiovascular Prevention, 2023, 30 : 17 - 27
  • [38] Subclinical target organ damage in patients with essential hypertension
    Gajewska, Magdalena
    Michalak, Ewa
    Hoffman, Piotr
    Januszewicz, Andrzej
    ARTERIAL HYPERTENSION, 2005, 9 (03): : 157 - 167
  • [39] Serumuric acid and the relationshipwith subclinical organ damage in adults
    Lambert, Elisabeth A.
    Hachem, Mariam
    Hemmes, Robyn
    Straznicky, Nora E.
    Eikelis, Nina
    Sari, Carolina I.
    Schlaich, Markus P.
    Lambert, Gavin W.
    Dixon, John B.
    JOURNAL OF HYPERTENSION, 2017, 35 (04) : 745 - 752
  • [40] BLOOD PRESSURE VARIABILITY AND SUBCLINICAL TARGET ORGAN DAMAGE
    Azevedo, O.
    Ferreira, F.
    Almeida, F.
    Ferreira, C.
    Guardado, J.
    Fernandes, M.
    Machado, I.
    Medeiros, R.
    Almeida, J.
    JOURNAL OF HYPERTENSION, 2010, 28 : E590 - E590